2026/2027 | 100 Q&A PMHNP Practice Exam | ANCC Blueprint
Integrated | Advanced Practice Psychiatric Nursing | Pass
Guaranteed - A+ Graded
Exam Specifications:
● Total Questions: 100 Multiple Choice Questions
● Cognitive Distribution: 25% Recall | 50% Application | 25% Analysis
● Format: 70% Scenario-Based Clinical Cases | 30% Direct Knowledge Recall
● Content Domains: Scientific Foundation (22%) | Advanced Practice Skills (27%) |
Diagnosis & Treatment (22%) | Psychotherapy & Theories (11%) |
Ethics/Legal/Cultural (17%)
SECTION I: SCIENTIFIC FOUNDATION & NEUROBIOLOGY
(Questions 1–22)
Q1: A 28-year-old patient with major depressive disorder asks about how
antidepressants work in the brain. The PMHNP explains that selective serotonin
reuptake inhibitors (SSRIs) primarily exert their therapeutic effect through which
neurobiological mechanism?
A. Direct agonism of postsynaptic serotonin 5-HT1A receptors
B. Blockade of presynaptic serotonin transporters (SERT), increasing synaptic serotonin
availability
C. Inhibition of monoamine oxidase, preventing serotonin breakdown
D. Antagonism of 5-HT2A receptors, reducing serotonin activity
Correct Answer: B
,Rationale: SSRIs work by blocking the serotonin transporter (SERT) on the presynaptic
neuron, preventing serotonin reuptake and thereby increasing synaptic concentration of
serotonin. This enhanced serotonergic neurotransmission occurs over days to weeks,
correlating with the delayed therapeutic onset. Option A is incorrect because SSRIs are
not direct receptor agonists; they work presynaptically. Option C describes MAOIs, not
SSRIs. Option D is incorrect because 5-HT2A antagonism is characteristic of atypical
antipsychotics and some antidepressants like mirtazapine, not SSRIs. The
neurobiological mechanism requires understanding of presynaptic versus postsynaptic
effects and the distinction between reuptake inhibition and receptor modulation.
Q2: A patient with bipolar disorder is prescribed lithium carbonate. The PMHNP
monitors for therapeutic effectiveness and toxicity by tracking serum levels. Which
pharmacokinetic parameter most significantly affects lithium's narrow therapeutic
index?
A. First-pass hepatic metabolism
B. Renal clearance without protein binding
C. Extensive cytochrome P450 metabolism
D. High plasma protein binding (95%)
Correct Answer: B
Rationale: Lithium has a narrow therapeutic index (0.6–1.2 mEq/L for maintenance;
1.0–1.5 mEq/L for acute mania) primarily because it is entirely eliminated by renal
excretion without hepatic metabolism, has negligible protein binding, and distributes in
total body water. Renal function changes (dehydration, NSAID use, ACE inhibitors)
dramatically alter lithium levels. Option A is incorrect because lithium undergoes no
,hepatic metabolism. Option C is incorrect as lithium is not a CYP450 substrate. Option
D is incorrect because lithium has essentially zero protein binding, which actually
contributes to its toxicity risk as free drug is immediately bioavailable. Understanding
lithium's unique pharmacokinetic profile is essential for safe prescribing.
Q3: Which neurotransmitter system dysfunction is most consistently implicated in the
pathophysiology of obsessive-compulsive disorder (OCD) based on current
neurobiological evidence?
A. Dopaminergic hyperactivity in the mesolimbic pathway
B. Serotonergic dysregulation in cortico-striato-thalamo-cortical (CSTC) circuits
C. GABAergic deficiency in the hippocampus and amygdala
D. Glutamatergic overactivity exclusively in the prefrontal cortex
Correct Answer: B
Rationale: The cortico-striato-thalamo-cortical (CSTC) circuits, involving orbitofrontal
cortex, caudate nucleus, and thalamus, show serotonergic dysregulation in OCD. This is
supported by the efficacy of serotonergic agents (clomipramine, SSRIs) and
neuroimaging studies showing altered serotonin receptor binding. Option A describes
schizophrenia and addiction pathways. Option C relates more to anxiety disorders
generally. Option D is partially correct regarding glutamate's role but "exclusively" is
incorrect—glutamate dysregulation involves multiple circuits, not just prefrontal cortex.
The CSTC circuitry model explains both the obsessive thoughts (cortical) and
compulsive behaviors (striatal) components.
, Q4: A patient asks why benzodiazepines work quickly for anxiety while SSRIs take
weeks. The PMHNP explains that benzodiazepines act directly on which receptor
complex to produce immediate anxiolytic effects?
A. NMDA glutamate receptors
B. GABA-A receptor chloride ion channels
C. 5-HT3 serotonin receptors
D. Alpha-2 adrenergic receptors
Correct Answer: B
Rationale: Benzodiazepines bind to the benzodiazepine recognition site on the GABA-A
receptor complex, allosterically enhancing GABA's binding and increasing chloride ion
influx, producing immediate neuronal hyperpolarization and anxiolytic effects. This
direct receptor modulation explains the rapid onset (minutes to hours) versus SSRIs'
indirect mechanism requiring neuroplastic changes. Option A describes ketamine's
mechanism. Option C relates to ondansetron and some antipsychotics. Option D
describes clonidine's mechanism. Understanding the distinction between direct
allosteric modulation (benzodiazepines) and reuptake inhibition (SSRIs) explains the
differential onset of action.
Q5: Which brain region is primarily responsible for the regulation of circadian rhythms
and sleep-wake cycles, making it a target for interventions in mood disorders with sleep
disturbances?
A. Hippocampus
B. Amygdala